AZTR (Azitra, Inc.) Short-Term Debt to Capital

This daily price chart for Azitra, Inc. (AZTR) reflects the price action of an asset currently valued at 0.05. Azitra, Inc. (AZTR) is implementing advanced dermatitis treatments through skin microbiome management. Business revenues will be based on the commercialization of modified bacteria-based drugs to combat infections. Meanwhile, significant R&D expenditures and liquidity risks are already priced into the stock's market value.

To assess long-term risks, it is critical for an investor to understand the proportion of short-term liabilities within the equity structure, which allows them to track a company's dependence on liquidity via the short-term liabilities to equity chart on GURU.Markets; in the case of Azitra, Inc. (AZTR), this metric reflects financial stability during the execution of a costly R&D cycle to create genetically engineered bacteria for the therapy of Netherton syndrome.